Haemophilia B: database of point mutations and short additions and deletions—fourth edition, 1993

This publication has 88 references indexed in Scilit:

• Assessment of Outcome in Patients with Low-Back Pain
  Spine, 1992
• Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities
  Biochemistry, 1991
• Evidence that descendants of three founders constitute about 25% of hemophilia B in the united states
  Genomics, 1991
• Genetics and molecular biology of haemophilias A and B
  Blood Coagulation & Fibrinolysis, 1991
• Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity
  British Journal of Haematology, 1991
• Human factor IXLincoln Park: a molecular characterization
  Molecular and Cellular Probes, 1990
• A past mutation at Isoleucine³⁹⁷ is now a common cause of moderate/mild haemophilia B
  British Journal of Haematology, 1990
• Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B
  Nature, 1990
• Factor IX Kawachinagano: impaired function of the Gla‐domain caused by attached propeptide region due to substitution of arginine by glutamine at position −4
  British Journal of Haematology, 1989
• Identification of a CpG mutation in the coagulation factor‐IX gene by analysis of amplified DNA sequences
  British Journal of Haematology, 1988